NEUTROPENIA
Clinical trials for NEUTROPENIA explained in plain language.
Never miss a new study
Get alerted when new NEUTROPENIA trials appear
Sign up with your email to follow new studies for NEUTROPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a drug boost blood cells and delay cancer in people with CCUS?
Disease control Recruiting nowThis study tests the drug luspatercept in 50 adults with clonal cytopenias of uncertain significance (CCUS), a condition where blood cell counts are low and there is a risk of developing blood cancer. Participants receive injections every three weeks for up to 48 weeks. The goal …
Matched conditions: NEUTROPENIA
Phase: PHASE2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated May 17, 2026 04:15 UTC
-
New drug aims to boost infection defenses in rare blood disorder
Disease control Recruiting nowThis study tests an experimental drug called mavorixafor in people with chronic neutropenia, a condition where the body doesn't make enough neutrophils (a type of white blood cell), leading to frequent or serious infections. The goal is to see if the drug can safely raise neutrop…
Matched conditions: NEUTROPENIA
Phase: PHASE3 • Sponsor: X4 Pharmaceuticals • Aim: Disease control
Last updated May 04, 2026 16:30 UTC
-
New drug trial offers hope for rare immune disorder
Disease control Recruiting nowThis study is testing whether Mozobil, a drug already used for bone marrow transplants, can safely improve white blood cell counts in adults with WHIMS syndrome. WHIMS is a rare genetic disorder that causes severe infections, warts, and low white blood cells. Researchers will giv…
Matched conditions: NEUTROPENIA
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Apr 21, 2026 12:44 UTC
-
New shot aims to stop dangerous infection risk in cancer patients
Prevention Recruiting nowThis study looks at whether a medicine called mecapegfilgrastim can help prevent neutropenia (dangerously low white blood cells) in cancer patients after chemotherapy, radiation, or immunotherapy. About 200 adults with solid tumors will receive the injection to see if it reduces …
Matched conditions: NEUTROPENIA
Sponsor: Hebei Medical University Fourth Hospital • Aim: Prevention
Last updated May 11, 2026 20:49 UTC
-
Blood cancer patients may get relief from G-CSF bone pain with simple pills
Symptom relief Recruiting nowThis study compares two oral medications—diosmin-hesperidin (a plant-based supplement) and loratadine (an allergy drug)—to prevent severe bone pain caused by G-CSF, a medicine that boosts white blood cells in people with blood cancers. About 88 adults receiving G-CSF for leukemia…
Matched conditions: NEUTROPENIA
Phase: NA • Sponsor: Alexandria University • Aim: Symptom relief
Last updated May 07, 2026 18:42 UTC